Company · CIK 0001840233 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Xilio Therapeutics, Inc. · XLO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Akintunde Olatokumbo BelloDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | James Samuel ShannonDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Daniel J. CurranDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Yuan XuDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Robert W. RossDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Sara BonsteinDirector | 5,000 | — | — | 5,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 4:07 pm EDT | Aoife BrennanDirector | 5,000 | — | — | 5,000 | — |